Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 804.89 Million SEK | 134.97% |
| 2022 | 342.55 Million SEK | 10.91% |
| 2021 | 308.85 Million SEK | 87.3% |
| 2020 | 164.89 Million SEK | 1.5% |
| 2019 | 162.45 Million SEK | 40.89% |
| 2018 | 115.3 Million SEK | 24.86% |
| 2017 | 92.34 Million SEK | 14.82% |
| 2016 | 80.42 Million SEK | 15.7% |
| 2015 | 69.5 Million SEK | 24.81% |
| 2014 | 55.69 Million SEK | -10.67% |
| 2013 | 62.34 Million SEK | -7.08% |
| 2012 | 67.08 Million SEK | 3.65% |
| 2011 | 64.72 Million SEK | 12.95% |
| 2010 | 57.3 Million SEK | -7.35% |
| 2009 | 61.85 Million SEK | 4.43% |
| 2008 | 59.22 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.02 Billion SEK | 0.88% |
| 2024 Q2 | 1.01 Billion SEK | 1.63% |
| 2024 Q1 | 1 Billion SEK | 24.36% |
| 2023 Q3 | 370.7 Million SEK | 1.73% |
| 2023 Q1 | 349.3 Million SEK | 1.97% |
| 2023 Q4 | 804.89 Million SEK | 117.12% |
| 2023 Q2 | 364.41 Million SEK | 4.33% |
| 2023 FY | 804.89 Million SEK | 134.97% |
| 2022 Q2 | 326.76 Million SEK | 4.59% |
| 2022 Q3 | 338.91 Million SEK | 3.72% |
| 2022 Q4 | 342.55 Million SEK | 1.07% |
| 2022 Q1 | 312.4 Million SEK | 1.15% |
| 2022 FY | 342.55 Million SEK | 10.91% |
| 2021 FY | 308.85 Million SEK | 87.3% |
| 2021 Q1 | 173.86 Million SEK | 5.44% |
| 2021 Q2 | 168.78 Million SEK | -2.92% |
| 2021 Q3 | 313.22 Million SEK | 85.57% |
| 2021 Q4 | 308.85 Million SEK | -1.39% |
| 2020 FY | 164.89 Million SEK | 1.5% |
| 2020 Q4 | 164.89 Million SEK | 5.14% |
| 2020 Q3 | 156.83 Million SEK | 0.06% |
| 2020 Q2 | 156.74 Million SEK | -4.48% |
| 2020 Q1 | 164.09 Million SEK | 1.01% |
| 2019 Q1 | 123.32 Million SEK | 6.95% |
| 2019 Q3 | 128.1 Million SEK | 5.4% |
| 2019 Q4 | 162.45 Million SEK | 26.81% |
| 2019 Q2 | 121.54 Million SEK | -1.44% |
| 2019 FY | 162.45 Million SEK | 40.89% |
| 2018 Q2 | 99.78 Million SEK | -0.76% |
| 2018 FY | 115.3 Million SEK | 24.86% |
| 2018 Q4 | 115.3 Million SEK | 12.62% |
| 2018 Q3 | 102.38 Million SEK | 2.6% |
| 2018 Q1 | 100.54 Million SEK | 8.88% |
| 2017 Q3 | 89.9 Million SEK | 3.83% |
| 2017 Q2 | 86.58 Million SEK | 0.02% |
| 2017 Q1 | 86.56 Million SEK | 7.64% |
| 2017 FY | 92.34 Million SEK | 14.82% |
| 2017 Q4 | 92.34 Million SEK | 2.72% |
| 2016 Q2 | 71.52 Million SEK | -1.23% |
| 2016 Q1 | 72.41 Million SEK | 4.19% |
| 2016 FY | 80.42 Million SEK | 15.7% |
| 2016 Q4 | 80.42 Million SEK | 8.22% |
| 2016 Q3 | 74.31 Million SEK | 3.9% |
| 2015 Q2 | 61.21 Million SEK | 3.45% |
| 2015 Q1 | 59.17 Million SEK | 6.25% |
| 2015 FY | 69.5 Million SEK | 24.81% |
| 2015 Q4 | 69.5 Million SEK | 8.36% |
| 2015 Q3 | 64.14 Million SEK | 4.79% |
| 2014 Q3 | 55.14 Million SEK | -4.09% |
| 2014 Q2 | 57.49 Million SEK | -4.81% |
| 2014 Q1 | 60.4 Million SEK | -3.11% |
| 2014 FY | 55.69 Million SEK | -10.67% |
| 2014 Q4 | 55.69 Million SEK | 0.99% |
| 2013 Q2 | 69.28 Million SEK | 5.26% |
| 2013 Q1 | 65.82 Million SEK | -1.88% |
| 2013 FY | 62.34 Million SEK | -7.08% |
| 2013 Q3 | 61.99 Million SEK | -10.53% |
| 2013 Q4 | 62.34 Million SEK | 0.56% |
| 2012 Q2 | 66.09 Million SEK | -3.81% |
| 2012 Q1 | 68.71 Million SEK | 6.16% |
| 2012 Q3 | 68.41 Million SEK | 3.51% |
| 2012 Q4 | 67.08 Million SEK | -1.94% |
| 2012 FY | 67.08 Million SEK | 3.65% |
| 2011 Q2 | 60.55 Million SEK | 2.28% |
| 2011 Q1 | 59.2 Million SEK | 3.32% |
| 2011 FY | 64.72 Million SEK | 12.95% |
| 2011 Q3 | 62.5 Million SEK | 3.22% |
| 2011 Q4 | 64.72 Million SEK | 3.55% |
| 2010 Q1 | 55.28 Million SEK | -10.62% |
| 2010 FY | 57.3 Million SEK | -7.35% |
| 2010 Q4 | 57.3 Million SEK | 13.54% |
| 2010 Q3 | 50.47 Million SEK | -8.0% |
| 2010 Q2 | 54.85 Million SEK | -0.77% |
| 2009 FY | 61.85 Million SEK | 4.43% |
| 2009 Q4 | 61.85 Million SEK | 0.0% |
| 2009 Q2 | 59.28 Million SEK | -11.49% |
| 2009 Q1 | 66.97 Million SEK | 0.0% |
| 2008 FY | 59.22 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -1179.966% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 75.516% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 75.516% |
| Arcoma AB | 81.96 Million SEK | -882.033% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | -17.868% |
| BICO Group AB (publ) | 10.19 Billion SEK | 92.106% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | -6.594% |
| CellaVision AB (publ) | 928.71 Million SEK | 13.332% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -1294.359% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -3566.028% |
| C-Rad AB (publ) | 404 Million SEK | -99.231% |
| Duearity AB (publ) | 15.14 Million SEK | -5214.937% |
| Dignitana AB (publ) | 44.83 Million SEK | -1695.396% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -671.71% |
| Getinge AB (publ) | 55.09 Billion SEK | 98.539% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -684.204% |
| Iconovo AB (publ) | 128.07 Million SEK | -528.431% |
| Integrum AB (publ) | 164.85 Million SEK | -388.231% |
| Luxbright AB (publ) | 40.68 Million SEK | -1878.275% |
| Mentice AB (publ) | 322.52 Million SEK | -149.559% |
| OssDsign AB (publ) | 356.38 Million SEK | -125.847% |
| Paxman AB (publ) | 167.12 Million SEK | -381.612% |
| Promimic AB (publ) | 92.87 Million SEK | -766.642% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -1961.399% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -1151.118% |
| ScandiDos AB (publ) | 81.47 Million SEK | -887.927% |
| Sectra AB (publ) | 3.21 Billion SEK | 74.933% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 20.626% |
| Senzime AB (publ) | 433.54 Million SEK | -85.655% |
| SpectraCure AB (publ) | 144.83 Million SEK | -455.736% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 95.089% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 63.341% |